X Technologies Inc.

Since its spin-off, Guidant has built itself into a cardiovascular giant through deft technology innovation. But a series of mis-steps has forced this former start-up to quickly grow up. By David Cass

In a recent series of deals, Guidant Corp. looked both to make-up lost ground in the drug-eluting stent (DES) race and leap-frog ahead to the next-next big thing in stents by creating a separate bu